Lung infections are a common respiratory disease, mainly those caused by pathogens such as bacteria, viruses and trigenes. The following are common treatments:
I. Anti-infection treatment
Antibiotic treatment (for bacterial infections)
Empirical medicines: When the pathogen is not yet clear, doctors usually use them on the basis of the patient ‘ s symptoms, history, age, local epidemiology, etc. For example, in the case of community access to sexually transmitted pneumonia, antibiotics such as Amosicillin and Achicillin may be used if the patient is less ill, and antibacterial drugs such as thawing and left-oxen fluoride may be selected if the disease is more severe.
Targeted medicines: Once the pathogen and the drug-sensitive results have been identified through tests such as sapling, blood culture, etc., targeted antibiotics are selected. For example, phenolicillin is used for treatment if it is golden fungus and is sensitive to phenolin, and in the case of methylenedioxysilin-yellen fungus (MRSA) infection, it may require the use of vancin or linazine.
Antiviral treatment (for viral infections)
Common drugs: In the case of lung infections caused by influenza viruses, the use of anti-influenza virus drugs, such as Ostawe, Zanamwe and others, within 48 hours of the onset of the disease can be effective in mitigating symptoms and reducing the duration of the disease. For other viruses, such as the CMV infection, more ros-love may be used; for the simple herpes virus (HSV) infection, Atzlove is a common drug.
Timing of treatment: The timing of antiviral treatment is critical, and the early use of antivirals is more effective, so people with suspected viral infections need to be tested as soon as possible for timely treatment.
Antitrigen treatment (for secondary infections)
Drug selection: Pyramids do not have cytowalls, so they are not sensitive to β-neamide antibiotics (e.g. penicillin, sepsis). The treatment of secondary lung infections is mainly based on the use of Great Cyclactin (e.g., Achicillin, erythrin) or tetracyclic antibiotics (e.g., Dossi, Minocrin).
The treatment process requires that anti-systroid treatment usually requires a longer treatment, and Achcin is usually used for three days and four days, which lasts two to three weeks, to ensure the complete removal of the pathogens.
II. Treatment
Reheating treatment
Physical cooling: When the patient ‘ s body temperature is below 38.5°C, physical cooling is generally used, for example, to wipe the head, armpit, groin, etc. of the patient with warm water, or to reduce the temperature by dissipation.
Drug cooling: Drugs can be used to cool down when body temperature exceeds 38.5°C. Common defunct drugs include acetaminophenol, brovent, etc., which can produce vascular expansion and sweat to thermal reheating by inhibiting the synthesis and release of central prostate (PGE1) in the hypothalamus.
cough treatment
Accelerants: Accelerants can be properly used if the patient coughs severely, affecting rest and sleep. When the cough is dry, a central cough control drug such as the right methadone may be used, and if the cough is accompanied by a small amount of white accelerant, an option may be used for cough control pills such as toverin.
Peptice: When the patient has more sluice and is adhesive, the main use is gills, such as ammonium chloride, which can increase the flow of mucous glands in the respiratory tract and reduce the mucous gland, thus reducing the mucousity of the slurry and making it easy to cough.
III. Support for treatment
Oxygen.
Oxygen: Oxygen saturation between 90% and 94% of haematological oxygen can be absorbed through a nasal catheter with a general oxygen flow of 1-2L/min to increase haematological oxygen content and to improve oxygen deficiency symptoms.
Mask oxygen or no gas: For patients with severe respiratory difficulties with blood oxygen saturation below 90%, mask oxygen may be required, and oxygen flow may be adjusted to the patient ‘ s specific circumstances. If the patient has respiratory failure, there may be a need for a lack of inhalation, such as the use of a two-level airway positive-pressure (BiPAP) device to help the patient breathe.
Nutritional support
(b) Dietary adjustment: The patient is encouraged to consume sufficient nutrition and to eat more protein-, vitamin- and heat-rich food, such as eggs, milk, fish meat, vegetables and fruit. If the patient is unable to eat normally, the nutrient can be replenished by nasal feed or intravenous infusion of nutrients to increase the resilience of the body and promote rehabilitation
